article thumbnail

Process improvements and in-person monitoring help U.S. pharmaceutical company achieve on time for Phase III clinical trials

Impact Pharmaceutical Services

Process improvements and in-person monitoring by Syner-G helped the client to get the DS with the right quality and quantity on time for Phase III clinical trials. Download The Case Study The post Process improvements and in-person monitoring help U.S.

article thumbnail

ADCs Reap the Benefits of Continual Research and Process Improvements

BioPharm

Deeper biological understanding and technology innovations have improved the fate of ADC development.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CPHI Experts Report that Small to Mid-sized US CDMOs Must Invest Now to Benefit from 2025 Contract Funding Surge

BioPharm

Key areas to invest include manufacturing process improvements, quality management, and AI.

article thumbnail

Single-use technology propelling upstream bioprocessing market expansion

European Pharmaceutical Review

The authors also noted that growth of the upstream bioprocessing market is being pushed by the need for process improvement, and because “processing equipment consumption has expanded”.

article thumbnail

XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform

Pharmaceutical Technology

CK Life Sciences vice-president and chief scientific officer Dr Melvin Toh said: “The cooperation with XtalPi will apply XtalPi’s AI algorithm, molecular modelling and automated experiments to speed up the R&D process, improve the success rate, and increase the efficacy of tumour vaccines.”.

article thumbnail

Pharmacy’s digital transformation spotlighted in new FIP report

Hospital Pharmacy Europe

Digital advancements have the potential to revolutionise hospital pharmacy by streamlining processes, improving medication safety and enhancing patient care, a new report from the International Pharmaceutical Federation (FIP) has concluded.

article thumbnail

Genentech to open new high-tech biologics facility

European Pharmaceutical Review

When operational in early 2025, the new facility will be the first commercial biopharma manufacturing facility to incorporate the latest manufacturing technologies along with in-house process improvements for increased flexibility, speed and output under one roof.